Perforin-independent CD8+ T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-α: Relative insensitivity to Fas ligand

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 849-858

  Liu, Angela Ning ^b   Mohammed, Ashraf Z ^b   Rice, Ward R ^b   Fiedeldey, Dana T ^b   Liebermann, Jennifer S ^b   Whitsett, Jeffrey A ^b   Braciale, Thomas J ^b   Enelow, Richard I ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE; MUS MUSCULUS;

FAS LIGAND; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL LINE; CYTOLOGY; CYTOTOXICITY; EPITHELIUM CELL; IMMUNOLOGY; LUNG ALVEOLUS; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIAL CELLS; FAS LIGAND PROTEIN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PORE FORMING CYTOTOXIC PROTEINS; PULMONARY ALVEOLI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033126396     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3585     Document Type: Article

References (76)

1. Costabel, U., H. Teschler, and J. Guzman. 1992. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur. Respir. J. 5:791-797.
2. Katzenstein, A. 1997. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. W.B. Saunders, Philadelphia.
3. Kradin, R. L., M. B. Divertie, R. B. Colvin, J. Ramirez, J. Ryu, H. A. Carpenter, and A. K. Bhan. 1986. Usual interstitial pneumonitis is a T-cell alveolitis. Clin. Immunol. Immunopathol. 40:224-235.
4. Leatherman, J., A. Michael, B. Schwartz, and J. Hoidal. 1984. Lung T cells in hypersensitivity pneumonitis. Ann. Intern. Med. 100:390-396.
5. Lukacher, A. E., L. A. Morrison, V. L. Braciale, and T. J. Braciale. 1986. T lymphocyte function in recovery from experimental viral infection: the influenza model. In Mechanisms of Host Resistance to Infectious Agents, Tumors, and Allografts. R. M. Steinman, editor. Rockefeller University Press, New York. 233-254.
6. Yap, K. L., T. J. Braciale, and G. L. Ada. 1979. Role of T-cell function in recovery from murine influenza infection. Cell. Immunol. 43:341-351.
7. Wells, M. A., P. Albrecht, and F. A. Ennis. 1981. Recovery from a viral respiratory infection: I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 126:1036-1041.
8. Couch, R. B., and J. Kasel. 1983. Immunity to influenza in man. Annu. Rev. Microbiol. 37:529-549.
9. Ada, G., and P. Jones. 1986. The immune responses to influenza infection. Curr. Top. Microbiol. Immunol. 128:1-54.
10. Ada, G., and P. Jones. 1987. The cell-mediated and humoral responses to influenza virus infection in the mouse lung. Adv. Exp. Med. Biol. 216B: 1033-1042.
11. Andrew, M. E., V. L. Braciale, T. J. Henkel, J. A. Hatch, and T. J. Braciale. 1985. Stable expression of cytolytic activity by influenza virus-specific cytotoxic T lymphocytes. J. Immunol. 135:3520-3523.
12. Henkart, P. 1993. Cytotoxic Cells. Birkhauser, Boston. 9-45.
13. Kojima, H., N. Shiohara, S. Hanaoka, Y. Shirota, Y. Takagaki, H. Ohno, T. S. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. Alt, A. Matsuzawa, S. Yonehara, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364.
14. Braciale, T. J., C. F. Mojcik, and V. Hauptfeld. 1982. Target-cell recognition by cloned lines of influenza virus-specific cytotoxic T lymphocytes: selective inhibition by a monoclonal H-2-specific antibody. Immunogenetics 15:41-52.
15. Henkart, P. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343-346.
16. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Nengartner, and P. Golstein. 1994. Fas and perforin as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
17. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652.
18. Walsh, C., M. Matloubian, C. Lui, R. Udea, C. Kurahara, J. Christiansen, M. Huang, J. Young, R. Ahmed, and W. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854-10858.
19. Walsh, C. M., A. A. Glass, V. Chiu, and W. R. Clark. 1994. The role of the Fas lytic pathway in a perforin-less CTI. hybridoma. J. Immunol. 153:2506-2514.
20. Alderson, M. R., T. W. Tough, S. T. Davis, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
21. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444.
22. Crispe, I. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347-349.
23. Dhein, J., H. Walczak, C. Baumler, K. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 3734:438-448.
24. + T cells responding to a bacterial superantigen. J. Immunol. 154:4302-4308.
25. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homcostatic regulation of immune responses. Immunol. Today 16:569-574.
26. Seino, K., N. Kayagaki, K. Takeda, K. Fukao, K. Okumura, and H. Yagita. 1997. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113:1315-1322.
27. Pensati, L., A. Costanzo, A. Ianni, D. Accapezzato, R. Iorio, G. Natoli, R. Nisini, C. Almerighi, C. Balsano, P. Vajro, A. Vegnente, and M. Levrero. 1997. Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 113:1384-1389.
28. Luo, K. X., Y. F. Zhu, L. X. Zhang, H. T. He, X. S. Wang, and L. Zhang. 1997. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J. Viral Hepatol. 4:303-307.
29. Hayashi, N., and E. Mita. 1997. Fas system and apoptosis in viral hepatitis. J. Gastroenterol. Hepatol. 12:S223-S226.
30. Galle, P., W. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
31. Takehara, T., N. Hayashi, E. Mita, T. Kanto, T. Tatsumi, Y. Sasaki, A. Kasahara, and M. Hori. 1998. Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNF-alpha. Hepatology 27:1643-1651.
32. Schneider, P., N. Holler, J. L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213.
33. Chandler, J. M., G. M. Cohen, and M. MacFarlane. 1998. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. 273:10815-10818.
34. French, L. E., and J. Tschopp. 1997. Thyroiditis and hepatitis: Fas on the road to disease. Nature Med. 3:387-388.
35. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis (see comments). Science 275:960-963.
36. Itoh, N., A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, S. Makino, S. Nagata, N. Kono, and Y. Matsuzawa. 1997. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:613-618.
37. Gochuico, B. R., K. M. Miranda, E. M. Hessel, J. J. De Bie, A. J. Van Oosterhout, W. W. Cruikshank, and A. Fine. 1998. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am. J. Physiol. 274:L444-L449.
38. Kazufumi, M., N. Sonoko, K. Masanori, I. Takateru, and O. Akira. 1997. Expression of bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis. Microsc. Res. Tech. 38: 480-487.
39. Spinozzi, F., M. Fizzotti, E. Agea, S. Piattoni, S. Droetto, A. Russano, N. Forenza, G. Bassotti, F. Grignani, and A. Bertotto. 1998. Defective expression of Fas messenger RNA and Fas receptor on pulmonary T cells from patients with asthma. Ann. Intern. Med. 128:363-369.
40. Tomokuni, A., T. Aikoh, T. Matsuki, Y. Isozaki, T. Otsuki, S. Kita, H. Ueki, M. Kusaka, T. Kishimoto, and A. Ueki. 1997. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin. Exp. Immunol. 110:303-309.
41. Nomoto, Y., K. Kuwano, N. Hagimoto, R. Kunitake, M. Kawasaki, and N. Hara. 1997. Apoptosis and Fas/Fas ligand mRNA expression in acute immune complex alveolitis in mice. Eur. Respir. J. 10:2351-2359.
42. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91-101.
43. Hagimoto, N., K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko, and N. Hara. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-278.
44. Gochuico, B. R., M. C. Williams, and A. Fine. 1997. Simultaneous in situ hybridization and TUNEL to identify cells undergoing apoptosis. Histochem. J. 29:413-418.
45. Fine, A., N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico. 1997. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273:L64-L71.
46. Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones, and P. A. Ward. 1995. Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J. Immunol. 154:4793-4802.
47. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
48. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. D. Lynch, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
49. + cytotoxic T lymphocyte-mediated lysis. J. Immunol. 150:4303-4314.
50. Enelow, R., M. Stoler, A. Srikiatkhachorn, C. Kerlakian, S. Agersborg, J. Whitsett, and T. Braciale. 1996. A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. J. Clin. Invest. 98:914-922.
51. Enelow, R. I., A. Z. Mohammed, M. H. Stoler, J. S. Young, Y. H. Lou, and T. J. Braciale. 1998. Experimental T cell-mediated lung disease: structural and functional consequences of alveolar cell recognition by CD8+ T lymphocytes. J. Clin. Invest. 102:1653-1661.
52. Wikenheiser, K., D. Vorbroker, W. Rice, J. Clark, C. Bachurski, H. Oie, and J. Whitsett. 1993. Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc. Natl. Acad. Sci. USA 90:11029-11033.
53. Graham, M., T. Braciale, and V. Braciale. 1996. Use of antiviral T-lymphocyte clones to characterize antigen presentation and T-lymphocyte subsets. Methods: A Companion to Methods in Enzymology 9:439-444.
54. Cao, W., S. S. Tykodi, M. T. Esser, V. L. Braciale, and T. J. Braciale. 1995. Partial activation of CD8+ T cells by a self-derived peptide. Nature 378: 295-298.
55. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185-192.
56. Corti, M., A. R. Brody, and J. H. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14:309-315.
57. Maldonado, M. A., R. A. Eisenberg, E. Roper, P. L. Cohen, and B. L. Kotzin. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641-648.
58. Hartsfield, C., D. Lipke, Y. Lai, D. Cohen, and M. Gillespie. 1997. Pulmonary mechanical and immunologic dysfunction in a murine model of AIDS. Am. J. Physiol. 272 (Lung Cell Mol. Physiol. 16):L699-L706.
59. Takezawa, J., F. Miller, and J. O'Neil. 1980. Single-breath diffusing capacity and lung volumes in small laboratory mammals. J. Appl. Physiol.: Respir. Environ. Exerc. Physiol. 48:1052-1059.
60. Sabo, J., E. Kimmel, and L. Diamond. 1983. Effects of the Clara cell toxin, 4-ipomeanol, on pulmonary function in rats. J. Appl. Physiol. 54:337-344.
61. Depledge, M., C. Collis, and A. Barrett. 1981. A technique for measuring carbon monoxide uptake in mice. Int. J. Radiat. Oncol. Biol. Phys. 7:485-489.
62. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305-1308.
63. Binder, C., L. Binder, M. Kroemker, M. Schulz, and W. Hiddemann. 1997. Influence of cycloheximide-mediated downregulation of glucose transport on TNF alpha-induced apoptosis. Exp. Cell Res. 236:223-230.
64. Sanchez-Alcazar, J. A., J. Ruiz-Cabello, I. Hernandez-Munoz, P. S. Pobre, P. de la Torre, E. Siles-Rivas, I. Garcia, O. Kaplan, M. T. Munoz-Yague, and J. A. Solis-Herruzo. 1997. Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death. J. Biol. Chem. 272:30167-30177.
65. Smyth, M. J., E. Krasovskis, and R. W. Johnstone. 1998. Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J. Virol. 72:5948-5954.
66. Kojima, H., K. Eshima, H. Takayama, and M. V. Sitkovsky. 1997. Leukocyte function-associated antigen-1-dependent lysis of Fas+ (CD95+/Apo-1+) innocent bystanders by antigen-specific CD8+ CTL. J. Immunol. 159: 2728-2734.
67. Fine, A., and N. Anderson. 1996. Expression, function and regulation of alveolar type II cell Fas. Am. J. Respir. Crit. Care Med. 153:A537. (Abstr.)
68. Pang, H., K. Miranda, and A, Fine. 1998. Sp3 regulates fas expression in lung epithelial cells. Biochem. J. 333:209-213.
69. Lynch, D. H. 1994. Biology of Fas. Circulatory Shock 44:63-66.
70. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
71. Owen-Schaub, L. B., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580-1586.
72. Dao, T., J. W. Huleatt, R. Hingorani, and I. N. Crispe. 1997. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J. Immunol. 159:4261-4267.
73. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27:1207-1212.
74. Freiberg, R. A., D. M. Spencer, K. A. Choate, P. D. Peng, S. L. Schreiber, G.R. Crabtree, and P.A. Khavari. 1996. Specific triggering of the Fas signal transduction pathway in normal human keratinocytes. J. Biol. Chem. 271: 31666-31669.
75. Biancone, L., A. D. Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi. 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186:147-152.
76. Beutler, B., and C. Van Huffel. 1994. Unraveling function in the TNF ligand and receptor family. Science 264:667-668.